Search

everythinglearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Strontium ranelate is no longer available for treatment.

Gene variation affects prostate issues and hair loss.

Accurate diagnosis and early specialist referral are crucial for managing 46,XY Disorders of Sex Development.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Mutations in the DSG4 gene cause specific hair and scalp issues.

The AR gene is linked to male-pattern baldness, TNFSF4 to heart disease, SLC19A3 to BBGD, MCT8 to a syndrome, and segmental duplications to genetic variation.

Seven genetic variations in sheep's DSG4 gene are linked and affect wool traits.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

A child with skin and tooth symptoms was found to have a genetic mutation causing cardiocutaneous syndrome, leading to heart problems.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Rats had lasting erectile problems after stopping a certain medication.

Higher CRHR1 levels in AA patients lead to increased inflammation.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Genetic marker rs12558842 strongly linked to male hair loss.

The equine epididymis mainly uses type 1 5α-reductase, and both finasteride and dutasteride can inhibit its activity.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

A vitamin D receptor mutation causes rickets and affects immune responses.

AHR ligands could treat inflammatory skin diseases.